P30NS065780/NS/NINDS NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
2012	3
2014	3
2015	1
2016	1
2022	0

1

Cross-species translation of the Morris maze for Alzheimer's disease.

Possin KL, Sanchez PE, Anderson-Bergman C, Fernandez R, Kerchner GA, Johnson ET, Davis A, Lo I, Bott NT, Kiely T, Fenesy MC, Miller BL, Kramer JH, Finkbeiner S. Possin KL, et al. J Clin Invest. 2016 Feb;126(2):779-83. doi: 10.1172/JCI78464. Epub 2016 Jan 19. J Clin Invest. 2016. PMID: 26784542 Free PMC article.

2

Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits.

Min SW, Chen X, Tracy TE, Li Y, Zhou Y, Wang C, Shirakawa K, Minami SS, Defensor E, Mok SA, Sohn PD, Schilling B, Cong X, Ellerby L, Gibson BW, Johnson J, Krogan N, Shamloo M, Gestwicki J, Masliah E, Verdin E, Gan L. Min SW, et al. Nat Med. 2015 Oct;21(10):1154-62. doi: 10.1038/nm.3951. Epub 2015 Sep 21. Nat Med. 2015. PMID: 26390242 Free PMC article.

3

Loss of mitochondrial fission depletes axonal mitochondria in midbrain dopamine neurons.

Berthet A, Margolis EB, Zhang J, Hsieh I, Zhang J, Hnasko TS, Ahmad J, Edwards RH, Sesaki H, Huang EJ, Nakamura K. Berthet A, et al. J Neurosci. 2014 Oct 22;34(43):14304-17. doi: 10.1523/JNEUROSCI.0930-14.2014. J Neurosci. 2014. PMID: 25339743 Free PMC article.

4

Apolipoprotein E4 produced in GABAergic interneurons causes learning and memory deficits in mice.

Knoferle J, Yoon SY, Walker D, Leung L, Gillespie AK, Tong LM, Bien-Ly N, Huang Y. Knoferle J, et al. J Neurosci. 2014 Oct 15;34(42):14069-78. doi: 10.1523/JNEUROSCI.2281-14.2014. J Neurosci. 2014. PMID: 25319703 Free PMC article.

5

Progranulin protects against amyloid β deposition and toxicity in Alzheimer's disease mouse models.

Minami SS, Min SW, Krabbe G, Wang C, Zhou Y, Asgarov R, Li Y, Martens LH, Elia LP, Ward ME, Mucke L, Farese RV Jr, Gan L. Minami SS, et al. Nat Med. 2014 Oct;20(10):1157-64. doi: 10.1038/nm.3672. Epub 2014 Sep 28. Nat Med. 2014. PMID: 25261995 Free PMC article.

6

Bone marrow transplantation confers modest benefits in mouse models of Huntington's disease.

Kwan W, Magnusson A, Chou A, Adame A, Carson MJ, Kohsaka S, Masliah E, Möller T, Ransohoff R, Tabrizi SJ, Björkqvist M, Muchowski PJ. Kwan W, et al. J Neurosci. 2012 Jan 4;32(1):133-42. doi: 10.1523/JNEUROSCI.4846-11.2012. J Neurosci. 2012. PMID: 22219276 Free PMC article.

7

Genetic Deficiency of Complement Component 3 Does Not Alter Disease Progression in a Mouse Model of Huntington's Disease.

Larkin PB, Muchowski PJ. Larkin PB, et al. J Huntingtons Dis. 2012;1(1):107-18. doi: 10.3233/JHD-2012-120021. J Huntingtons Dis. 2012. PMID: 23097680 Free PMC article.

8

Cannabinoid receptor 2 signaling in peripheral immune cells modulates disease onset and severity in mouse models of Huntington's disease.

Bouchard J, Truong J, Bouchard K, Dunkelberger D, Desrayaud S, Moussaoui S, Tabrizi SJ, Stella N, Muchowski PJ. Bouchard J, et al. J Neurosci. 2012 Dec 12;32(50):18259-68. doi: 10.1523/JNEUROSCI.4008-12.2012. J Neurosci. 2012. PMID: 23238740 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results